表紙
市場調査レポート

米国および欧州の糖尿病診断市場分析

Analysis of the US and European Diabetes Diagnostics Market

発行 Frost & Sullivan 商品コード 335085
出版日 ページ情報 英文 159 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
米国および欧州の糖尿病診断市場分析 Analysis of the US and European Diabetes Diagnostics Market
出版日: 2015年07月01日 ページ情報: 英文 159 Pages
概要

米国および欧州の糖尿病診断市場は長年成熟した段階にあり、両地域ともに糖尿病の高い罹患率によって成長が持続されています。非侵襲性技術は正確かつ高感度の結果をもたらしながら患者の痛みを減らすことで、今後大きく成長する見込みです。ポイントオブケア検査は米国では依然として安定して成長しており、効率と費用対効果、使いやすさから急速に発展すると予測されています。

当レポートでは、欧州および米国の糖尿病診断市場の概要と主なセグメント、それぞれの地域におけるセグメント別収益予測、および注目すべき企業などをまとめています。

第1章 エグゼクティブサマリー

第2章 市場概要

  • 糖尿病のイントロダクション
  • 市場概要
  • 市場セグメンテーション
  • セグメントライフサイクル分析
  • 競合セグメント分析
  • 将来的医療動向

第3章 競合プレイブック

  • 競合環境
  • 新たな市場の機会

第4章 全体市場分析

  • 評価
  • 仮定
  • 収益予測
  • セグメント概要
  • セグメント別収益予測
  • 収益予測に関する考察

第5章 米国市場

  • 市場促進因子
  • 市場阻害因子
  • 評価
  • 米国市場収益予測
  • セグメント概要
  • セグメント別収益予測
  • 収益予測に関する考察

第6章 米国のSMBG (血糖時モニタリング) セグメント

  • 評価
  • 収益予測
  • セグメント別収益予測
  • 収益予測に関する考察
  • 市場シェア分析

第7章 米国のPOCT (ポイントオブケア検査) セグメント

  • 評価
  • 収益予測
  • セグメント別収益予測
  • 収益予測に関する考察
  • 市場シェア分析

第8章 米国のラボ検査セグメント

  • 評価
  • 収益予測
  • セグメント別収益予測
  • 収益予測に関する考察
  • 市場シェア分析
  • ラボ検査動向
  • ラボ検査間の比較

第9章 欧州分析

  • 評価
  • 地位別収益予測
  • 収益予測に関する考察
  • セグメント概要

第10章 欧州のSMBGセグメント

  • 評価
  • 収益予測
  • セグメント別収益予測
  • 収益予測に関する考察
  • 市場シェア分析

第11章 欧州のPOCTセグメント

  • 評価
  • 収益予測
  • セグメント別収益予測
  • 収益予測に関する考察
  • 市場シェア分析

第12章 欧州のラボ検査セグメント

  • 評価
  • 収益予測
  • セグメント別収益予測
  • 収益予測に関する考察
  • 市場シェア分析
  • ラボ検査動向
  • ラボ検査間の比較

第13章 欧州の地域別分析

第14章 注目すべき企業

  • HemoCue
  • NovioSense
  • Miraculins

第15章 最後に

第16章 付録

図表

目次
Product Code: NF12-01-00-00-00

Constricting Reimbursement Policies Restrain Market Growth

The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-invasive technologies is disrupting this market space as it reduces patient pain points while providing accurate and sensitive results. Due to more hospital-centric care in the EU region, the POCT segment here experiences stronger growth than in the United States. POCT has the potential to grow the fastest due to its efficient, cost-effective solution and increasing adoption by physicians.

Key Questions this Study will Answer

  • What is the diabetes diagnostics market scenario in Europe and the United States?
  • How are the large exiting participants going to change this market?
  • Which are the major market segments, and what are the important trends that could affect market direction?
  • Who are the key market participants involved in each segment? What are their best practices in this market?
  • What are the key changes in the diabetes policy system of different regions in Europe and the United States and how will they affect the market in the future?
  • What is the future of the diabetes diagnostics market in Europe and the United States, and what should market participants do to succeed?

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Key Findings (continued)
  • 4. Scope and Segmentation
  • 5. Key Questions this Study will Answer
  • 6. Measurements
  • 7. CEO's Perspective
  • 8. Key Companies to Watch
  • 9. Executive Summary-3 Big Predictions

2. MARKET OVERVIEW

Market Overview

  • 1. Introduction to Diabetes
  • 2. Market Overview
  • 3. Market Segmentation
  • 4. Segment Life Cycle Analysis
  • 5. Market Segmentation
  • 6. Competitive Segment Analysis
  • 7. Defining Healthcare Trends in the Future

3. COMPETITIVE PLAYBOOK

Competitive Playbook

  • 1. Diabetes Diagnostics Market-Competitive Landscape
  • 2. New Market Opportunities
  • 3. New Market Opportunities (continued)
  • 4. Competitive Analysis
  • 5. Competitive Analysis (continued)
  • 6. Competitive Analysis (continued)
  • 7. Competitive Analysis (continued)
  • 8. Competitive Analysis (continued)

4. TOTAL MARKET ANALYSIS

Total Market Analysis

  • 1. Measurements
  • 2. Forecast Assumptions
  • 3. Revenue Forecast
  • 4. Segment Overview
  • 5. Revenue Forecast by Segment
  • 6. Revenue Forecast Discussion

5. US ANALYSIS

US Analysis

  • 1. Market Drivers
  • 2. Drivers Explained
  • 3. Drivers Explained (continued)
  • 4. Market Restraints
  • 5. Restraints Explained
  • 6. Measurements
  • 7. US Revenue Forecast
  • 8. Segment Overview
  • 9. Revenue Forecast by Segment
  • 10. Revenue Forecast Discussion

6. US SMBG SEGMENT

US SMBG Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Segment
  • 4. Revenue Forecast Discussion
  • 5. Market Share Analysis
  • 6. Market Share Analysis (continued)

7. US POCT SEGMENT

US POCT Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Segment
  • 4. Revenue Forecast Discussion
  • 5. Market Share Analysis

8. US LAB-BASED TESTING SEGMENT

US Lab-based Testing Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Market Share Analysis
  • 5. Lab-based Testing Trends
  • 6. Comparison of Lab-based Tests
  • 7. Comparison of Lab-based Tests (continued)

9. EUROPE ANALYSIS

Europe Analysis

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Region
  • 4. Revenue Forecast Discussion
  • 5. Segment Overview

10. EUROPE SMBG SEGMENT

Europe SMBG Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Segment
  • 4. Revenue Forecast Discussion
  • 5. Market Share Analysis

11. EUROPE POCT SEGMENT

Europe POCT Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast by Segment
  • 4. Revenue Forecast Discussion
  • 5. Market Share Analysis

12. EUROPE LAB-BASED TESTING SEGMENT

Europe Lab-based Testing Segment

  • 1. Measurements
  • 2. Revenue Forecast
  • 3. Revenue Forecast Discussion
  • 4. Market Share Analysis
  • 5. Lab-based Testing Segment Trends
  • 6. Comparison of Lab-based Tests
  • 7. Comparison of Lab-based Tests (continued)

13. EUROPE-REGIONAL ANALYSIS

Europe-Regional Analysis

  • 1. Regional Overview
  • 2. Revenue Forecast-The United Kingdom
  • 3. UK Regulations and Reimbursements
  • 4. Revenue Forecast by Segment-The United Kingdom
  • 5. UK Revenue Forecast Discussion
  • 6. UK Revenue Forecast Discussion (continued)
  • 7. UK Revenue Forecast Discussion (continued)
  • 8. UK Revenue Forecast Discussion (continued)
  • 9. Market Impact of Top 10 Trends
  • 10. Revenue Forecast-Germany
  • 11. Germany Reimbursements and Regulations
  • 12. Revenue Forecast by Segment-Germany
  • 13. Germany Revenue Forecast Discussion
  • 14. Germany Revenue Forecast Discussion (continued)
  • 15. Market Impact of Top 10 Trends
  • 16. Revenue Forecast-France
  • 17. France Reimbursements and Regulations
  • 18. France Reimbursements and Regulations (continued)
  • 19. Revenue Forecast by Segment-France
  • 20. France Revenue Forecast Discussion
  • 21. France Revenue Forecast Discussion (continued)
  • 22. France Revenue Forecast Discussion (continued)
  • 23. Market Impact of Top 10 Trends
  • 24. Revenue Forecast-Italy
  • 25. Italy Reimbursements and Regulations
  • 26. Revenue Forecast by Segment-Italy
  • 27. Italy Revenue Forecast Discussion
  • 28. Italy Revenue Forecast Discussion (continued)
  • 29. Market Impact of Top 10 Trends
  • 30. Revenue Forecast-Spain
  • 31. Spain Reimbursements and Regulations
  • 32. Revenue Forecast by Segment-Spain
  • 33. Spain Revenue Forecast Discussion
  • 34. Spain Revenue Forecast Discussion (continued)
  • 35. Market Impact of Top 10 Trends
  • 36. Revenue Forecast-Benelux (Belgium, the Netherlands, Luxembourg)
  • 37. Benelux Reimbursements and Regulations
  • 38. Benelux Reimbursements and Regulations (continued)
  • 39. Revenue Forecast by Segment-Benelux
  • 40. Benelux Revenue Forecast Discussion
  • 41. Revenue Forecast-Scandinavia
  • 42. Scandinavia Reimbursements and Regulations
  • 43. Revenue Forecast by Segment-Scandinavia
  • 44. Scandinavia Revenue Forecast Discussion
  • 45. Market Impact of Top 10 Trends

14. KEY COMPANIES TO WATCH

Key Companies to Watch

  • 1. HemoCue
  • 2. NovioSense
  • 3. Miraculins

15. THE LAST WORD

The Last Word

  • 1. The Last Word-3 Big Predictions

16. APPENDIX

Appendix

  • 1. Additional Studies of Interest
  • 2. Additional Studies of Interest (continued)
  • 3. Methodology
  • 4. List of Exhibits
  • 5. List of Exhibits (continued)
  • 6. List of Exhibits (continued)
  • 7. List of Exhibits (continued)
  • 8. List of Exhibits (continued)
  • 9. List of Exhibits (continued)
  • 10. List of Exhibits (continued)
  • 11. List of Exhibits (continued)

List of Exhibits

  • Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Percent Prevalence of Diabetes, Global, 2014
  • Total Diabetes Diagnostics Market: Market Segmentation, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Segment Life Cycle Analysis, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Percent Revenue Breakdown, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Competitive Segment Analysis, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Market Outlook, US and Europe, 2014 and 2024
  • Total Diabetes Diagnostics Market: Competitive Landscape, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Game-changing Strategies, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Top Product Analysis, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Market Engineering Measurements, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Revenue Forecast, US and Europe, 2011-2020
  • Total Diabetes Diagnostics Market by Segment: Percent Sales Breakdown, US and Europe, 2014
  • Total Diabetes Diagnostics Market: Percent Sales Breakdown, US and Europe, 2020
  • Total Diabetes Diagnostics Market: Revenue Forecast by Segment, US and Europe, 2011-2020
  • Diabetes Diagnostics Market: Key Market Drivers, US, 2015-2020
  • Diabetes Diagnostics Market: Key Market Restraints, US, 2015-2020
  • Diabetes Diagnostics Market: Market Engineering Measurements, US, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, US, 2011-2020
  • Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2014
  • Diabetes Diagnostics Market: Percent Sales Breakdown, US, 2020
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, US, 2011-2020
  • SMBG Segment: Market Engineering Measurements, US, 2014
  • SMBG Segment: Revenue Forecast, US, 2011-2020
  • SMBG Segment: Revenue Forecast by Sub-Segment, US, 2011-2020
  • SMBG Segment: Percent Revenue Breakdown, US, 2014
  • SMBG Segment: Market Positions of the Leading Participants, US, 2014
  • POCT Segment: Market Engineering Measurements, US, 2014
  • POCT Segment: Revenue Forecast, US, 2011-2020
  • POCT Segment: Revenue Forecast by Sub-Segment, US, 2011-2020
  • POCT Segment: Percent Revenue Breakdown, US, 2014
  • Lab-based HbA1c Testing Segment: Market Engineering Measurements, US, 2014
  • Lab-based HbA1c Testing Segment: Revenue Forecast, US, 2011-2020
  • Lab-based Testing Segment: Percent Revenue Breakdown, US, 2014
  • Diabetes Diagnostics Market: Trends of Lab-based Tests, US, 2014
  • FPG Testing Market: Market Potential, US, 2014
  • OGTT Testing Market: Market Potential, US, 2014
  • HbA1c Testing Market: Market Potential, US, 2014
  • Microalbumin Market: Market Potential, US, 2014
  • Diabetes Diagnostics Market: Market Engineering Measurements, Europe, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, Europe, 2011-2020
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Europe, 2011-2020
  • Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2014
  • Diabetes Diagnostics Market: Percent Sales Breakdown, Europe, 2020
  • SMBG Segment: Market Engineering Measurements, Europe, 2014
  • Diabetes Diagnostics Market: SMBG Revenue Forecast, Europe, 2011-2020
  • SMBG Segment: Revenue Forecast, Europe, 2011-2020
  • SMBG Segment: Percent Revenue Breakdown, Europe, 2014
  • POCT Segment: Market Engineering Measurements, Europe, 2014
  • POCT Segment: Revenue Forecast, Europe, 2011-2020
  • POCT Segment: Revenue Forecast by Segment, Europe, 2011-2020
  • POCT segment: Percent Revenue Breakdown, Europe, 2014
  • Lab-based HbA1c Testing Segment: Market Engineering Measurements, Europe, 2014
  • Lab-based HbA1c Testing Segment: Revenue Forecast, Europe, 2011-2020
  • Lab-based Testing Segment: Percent Revenue Breakdown, Europe, 2014
  • Diabetes Diagnostics Market: Trends of Lab-based Tests, Europe, 2014
  • FPG Testing Market: Market Potential, Europe, 2014
  • OGTT Testing Market: Market Potential, Europe, 2014
  • HbA1c Testing Market: Market Potential, Europe, 2014
  • Microalbumin Market: Market Potential, Europe, 2014
  • Diabetes Diagnostics Market: Percent Sales breakdown by Region, Europe, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, UK, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, UK, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, UK, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, UK, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, Germany, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, Germany, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Germany, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, Germany, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, France, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, France, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, France, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, France, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, Italy, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, Italy, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Italy, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, Italy, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, Spain, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, Spain, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Spain, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, Spain, 2014
  • Diabetes Diagnostics Market: Revenue Forecast, Benelux, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, Benelux, 2014
  • Diabetes Diagnostics Market: Demographic Information, the Netherlands, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Benelux, 2011-2020
  • Diabetes Diagnostics Market: Revenue Forecast, Scandinavia, 2011-2020
  • Diabetes Diagnostics Market: Demographic Information, Scandinavia, 2014
  • Diabetes Diagnostics Market: Revenue Forecast by Segment, Scandinavia, 2011-2020
  • Diabetes Diagnostics Market: Impact of Top 10 Trends, Benelux and Scandinavia, 2014
Back to Top